Oppenheimer Maintains Outperform on Amgen, Raises Price Target to $480

Benzinga · 2d ago
Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $450 to $480.